Abstract
Drug-induced
cardiotoxicity has become one of the major reasons leading to drug withdrawal in
past decades, which is closely related to the blockade of human
Ether-a-go-go-related gene (hERG) potassium channel. Developing reliable hERG predicting
model and optimizing model can greatly reduce the risk faced in drug discovery.
In this study, we constructed eight hERG classification models, the best of which
shows desirable generalization ability on low-similarity clinical compounds, as
well as advantages in perceiving activity gap caused by small structural
changes. Furthermore, we developed a hERG optimizer based on fragment grow
strategy and explored its usage in four cases. After reinforcement learning, our
model successfully suggests same or similar compounds as chemists’
optimization. Results suggest that our model can provide reasonable optimizing
direction to reduce hERG toxicity when hERG risk is corresponding to
lipophilicity, basicity, the number of rotatable bonds and pi-pi interactions. Overall,
we demonstrate our model as a promising tool for medicinal chemists in hERG optimization
attempts.